Cerestat CNS 1102 neuroprotective against glutamate action at the NMDA receptor data

CNSI presented Phase I/II data at an American Heart Association meeting in San Diego, showing more improvement

Read the full 178 word article

How to gain access

Continue reading with a
two-week free trial.